Year on year growth of import and export of traditional Chinese Medicine

Business news on May 21: in the first quarter of 2012, the import and export volume of traditional Chinese medicine reached 758 million US dollars, a year-on-year increase of 9.42%, of which the import volume was 169 million US dollars, a year-on-year increase of 20.46%; while the export volume of traditional Chinese medicine was 589 million US dollars, a year-on-year increase of 6.62% The import of Glycyrrhiza and its extract increased significantly year on year, mainly due to the significant increase in the import of Glycyrrhiza and its extract Licorice is one of the most important protected resource products in China and one of the national export quota management commodities It is widely used in medicine, food, cosmetics, cigarettes and other industries, and the global demand is increasing In order to alleviate the shortage of domestic resources, China has taken some encouraging measures for licorice import enterprises since 2008 After that, the import volume of licorice in China has increased year by year In 2011, the import volume of licorice in China reached a record high In the first quarter of 2012, the demand for licorice at home and abroad is still very strong, and the import growth of licorice in China has far exceeded the export growth Uzbekistan, Kazakhstan and other countries are rich in wild licorice resources with good quality, accounting for more than 80% of the total import of licorice in China Emerging markets, such as Russia, highlight vitality Japan, South Korea, ASEAN, Hong Kong, China and the United States are still the main export markets of traditional Chinese medicine Due to the single variety and serious homogenization competition, the export pressure of pharmaceutical enterprises has increased significantly However, the products of many traditional Chinese medicine enterprises are unique and special, with fixed market share and stable customers, and can control the initiative of foreign quotation Most of these enterprises quote in RMB, thus effectively avoiding the risk of exchange rate fluctuation to a large extent Russian health products market is one of the most attractive emerging markets in the world There are certain differences and complementarities between Russia and China in the development of pharmaceutical industry With the maturity and openness of the Russian market becoming higher and higher, the export of all kinds of traditional Chinese medicine products to Russia witnessed explosive growth for the first time last year At this Canton Fair, Chinese massage appliances and some health care products are favored by Russian businessmen In 2011, the export price of ginseng in China was $36770 / ton, up 84% from the same period In the first quarter of this year, the export price reached $43000 / ton, a record high China's Ginseng exports to Asia are mainly from Japan, Italy, Germany, the Netherlands, Hong Kong, China and Taiwan The market demand of Italy, Germany and the Netherlands has been increasing since 2011, and the export price is also rising However, China's ginseng price is still far lower than that of South Korea (Korea's Ginseng export price is up to $179603 / ton) The main reason is that Korean ginseng has been vigorously exploring the international market for many years, with high brand added value The main export areas are basically the same as Chinese ginseng In these countries and regions, Korean ginseng occupies the high-end market, while Chinese ginseng only occupies the low-end market At present, the increase of ginseng export price in China is partly due to product upgrading, such as processing ginseng crude products into extracts, or starting to operate organic products After the added value of products increases, not only the market demand is more vigorous, but also the price can be accepted by customers In addition, it is to improve the awareness of domestic ginseng brands There were more than 30 ginseng brands registered in Jilin Province, the main place of ginseng production before However, the product output of each brand is not large, the market coverage is narrow, and a national brand has not yet been formed In contrast, the most famous brand of Korean ginseng is zhengguanzhuang, with an annual output value of more than 2 billion US dollars It has an absolute advantage in Korean ginseng brand China is short of big brand of ginseng products, and also lacks the international competitiveness of ginseng industry However, on January 15, 2012, the first "Changbaishan ginseng" brand product store was put into trial operation, and achieved a good start This year, Jilin has established the brand marketing mode of "Changbaishan ginseng", using various publicity modes to form brand cohesion and brand benefit as soon as possible Third, the policy of increasing the price of ginseng from the source has achieved initial results In the past, China stipulated that ginseng could only be used for medicine but not for food, which restricted the development of ginseng health food in China In developed countries such as South Korea and the United States, ginseng can be used in food, so ginseng food is very popular in these countries Since March 1 this year, Jilin Province has implemented the "new measures for ginseng management", ginseng can be directly added to various foods as raw materials of food and beverage During the Canton Fair, the chamber of Commerce of medical insurance visited some Fusong ginseng enterprises Fusong ecological ginseng company reported that it had obtained the food batch number, so it could start to use ginseng as a pilot for domestic food sales With the implementation of "new methods for ginseng management" in Jilin Province, China's ginseng health food will open up a broad new road The export of traditional Chinese medicine to Taiwan has fallen to the "freezing point" According to the exhibitors of traditional Chinese medicine in the Canton Fair, there are many pharmaceutical merchants from Taiwan during the fair, but they are cautious in their purchase intention This is mainly due to the impact of Taiwan's implementation of control measures for imported Chinese herbal medicines Since September 1, 2011, Taiwan has fully implemented the source management and border management system for imported Chinese herbal medicines, and required mainland Chinese herbal medicines to provide official documents for testing according to Taiwan's testing methods when they are transported to Taiwan Moreover, the pesticide residue and heavy metal limit requirements for some Chinese herbal medicines are higher than those of Japan and South Korea 。 In the first quarter, Taiwan's export volume of 10 products, including jujube, eucommia, Poria, chuanxiong, Atractylodes macrocephala, peony, rehmannia, angelica, Astragalus and liquorice, which were under control in advance, declined to a certain extent Plant extract is the eternal sunrise industry Plant extract industry is the fastest growing industry in the export industry of traditional Chinese medicine It can also be said to be the eternal "sunrise industry" At the end of last year, the 12th Five year development plan for the food industry jointly issued by the national development and Reform Commission and the Ministry of industry and information technology clearly stated that "the development of natural pigment and plant extract industry will be encouraged and supported, and advantageous export products will continue to be developed" In 2011, the export of plant extracts reached US $1.13 billion, up 47% year-on-year, becoming the first commodity category of more than 1 billion in the export of traditional Chinese medicine In the first quarter of this year, China's export of extract reached US $299 million, up 11.71% year on year, accounting for 50.69% of the total export of traditional Chinese medicine The largest export category of plant extracts is natural pigment products, such as paprika red pigment, lutein and other food pigments In addition, flavors and fragrances extract is also an obvious growth in export volume Although the global economic growth slows down, the demand for plant extracts, as a rigid demand product, is still strong in the major economies of the world The import of plant extracts in the three major markets of the United States, Japan and the European Union increased significantly, especially in the United States and Japan In the first quarter, China's export of extracts to the two countries increased by 31.69% and 27.74% respectively In general, due to the severe world economic environment, the increase of enterprise cost and exchange rate, the export volume of traditional Chinese medicine in the first quarter decreased by about 18% year on year, with a large decrease mainly in traditional Chinese medicine and health care products The phenomenon of such a large decline in the export volume of traditional Chinese medicine commodities is rarely seen, and the import and export of traditional Chinese medicine will face great challenges in 2012 In this case, the existing export preferential policies should be maintained to create a good environment for enterprises to export.